These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19056513)

  • 1. Mutation research, genetic toxicology and environmental mutagenesis.
    Martus HJ; Suter W
    Mutat Res; 2009 Jan; 672(2):135. PubMed ID: 19056513
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo.
    Kirkland D; Speit G
    Mutat Res; 2008 Jul; 654(2):114-32. PubMed ID: 18585956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests.
    Kim BS; Margolin BH
    Environ Mol Mutagen; 1999; 34(4):297-304. PubMed ID: 10618179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of tests in yeasts and fungi in the detection and evaluation of carcinogens.
    Parry JM
    IARC Sci Publ; 1999; (146):471-85. PubMed ID: 10353399
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro mammalian cell genotoxicity assays: their use and interpretation.
    McGregor D
    Prog Clin Biol Res; 1990; 340B():159-69. PubMed ID: 2203003
    [No Abstract]   [Full Text] [Related]  

  • 7. Comet assay responses as indicators of carcinogen exposure.
    Anderson D; Yu TW; McGregor DB
    Mutagenesis; 1998 Nov; 13(6):539-55. PubMed ID: 9862185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rodent bone marrow micronucleus assay: contrast between its sensitivity to human carcinogens and its insensitivity to NTP rodent carcinogens.
    Ashby J; Tinwell H
    Mutat Res; 1996 Jun; 352(1-2):181-4. PubMed ID: 8676908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of major conclusions from the 4th IWGT, San Francisco, 9-10 September, 2005.
    Kirkland DJ; Hayashi M; Jacobson-Kram D; Kasper P; MacGregor JT; Müller L; Uno Y
    Mutat Res; 2007 Feb; 627(1):5-9. PubMed ID: 17137830
    [No Abstract]   [Full Text] [Related]  

  • 10. An overview of environmental mutagenesis in China.
    Hsueh JL; Yin MQ
    Prog Clin Biol Res; 1990; 340E():285-306. PubMed ID: 2392460
    [No Abstract]   [Full Text] [Related]  

  • 11. [Toxicological evaluation of inhalation noxae: test methods, assessment of toxic action and hazard potential, threshold limit values].
    Kleinsasser N
    Laryngorhinootologie; 2004 May; 83 Suppl 1():S36-53. PubMed ID: 15118947
    [No Abstract]   [Full Text] [Related]  

  • 12. Mathematical parameters for quantification of mutational responses in bacteria.
    Roldán-Arjona T; Pueyo C; Haynes RH
    Mutat Res; 1995 Feb; 346(2):77-84. PubMed ID: 7885403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate in vivo follow-up assays to an in vitro bacterial reverse mutation (Ames) test positive investigational drug candidate (active pharmaceutical ingredient), drug-related metabolite, or drug-related impurity.
    Robison TW; Heflich RH; Manjanatha MG; Elespuru R; Atrakchi A; Mei N; Ding W
    Mutat Res Genet Toxicol Environ Mutagen; 2021; 868-869():503386. PubMed ID: 34454692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals.
    Shirai T; Hirose M; Ito N
    IARC Sci Publ; 1999; (146):251-72. PubMed ID: 10353390
    [No Abstract]   [Full Text] [Related]  

  • 15. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints.
    Matthews EJ; Kruhlak NL; Cimino MC; Benz RD; Contrera JF
    Regul Toxicol Pharmacol; 2006 Mar; 44(2):83-96. PubMed ID: 16386343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinogenesis. Testing times for the tests.
    Hay A
    Nature; 1991 Apr; 350(6319):555-6. PubMed ID: 2017254
    [No Abstract]   [Full Text] [Related]  

  • 17. Using the comet and micronucleus assays for genotoxicity studies: A review.
    Araldi RP; de Melo TC; Mendes TB; de Sá Júnior PL; Nozima BH; Ito ET; de Carvalho RF; de Souza EB; de Cassia Stocco R
    Biomed Pharmacother; 2015 May; 72():74-82. PubMed ID: 26054678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of carcinogenic substances by means of short-term tests in bacteria.
    Quillardet P; McGregor D
    IARC Sci Publ; 1999; (146):487-97. PubMed ID: 10353400
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of short-and medium-term tests for carcinogens and data on genetic effects in carcinogenic hazard evaluation. Consensus report.
    IARC Sci Publ; 1999; (146):1-18. PubMed ID: 10353381
    [No Abstract]   [Full Text] [Related]  

  • 20. The Comet assay for the evaluation of genotoxic impact in aquatic environments.
    Frenzilli G; Nigro M; Lyons BP
    Mutat Res; 2009; 681(1):80-92. PubMed ID: 18439870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.